Table 1 Demography, medical history, baseline data and adverse events by suicide behaviors (attempts or completed suicide)
Variable | Patients without behaviors (n = 8487) | Patients with behavors (n = 384) |
|---|---|---|
Demographic data and medical history | ||
Age (years) mean ± SD | 40.1 ± 13.1 | 38.6 ± 11.8 |
Male gender (%pat) | 57.8% | 59.1% |
Employment (% pat) | 19.7% | 17.0% |
Social contacts in the previous 4 weeks (% pat) | 32.5% | 36.8% |
Time since first contact (years) mean ± SD | 11.4 ± 11.0 | 11.2 ± 10.2 |
Age at first contact (years) mean ± SD | 28.8 ± 10.6 | 27.4 ± 10.0 |
History of attempts (% pat) | 23.5% | 63.0% |
Attempts in the last 6 months (% pat) | 3.8% | 22.7% |
Hospitalizations due to schizophrenia (% pat) | 30.7% | 48.0% |
Concomitant treatment (% pat) | 19.0% | 20.6% |
Anticholinergics | 18.1% | 31.0% |
Antidepressants | 36.4% | 49.0% |
Anxiolyticis/hypnotics | 9.8% | 14.1% |
Mood stabilizer | ||
Baseline characteristics* (mean ± SD) | ||
Overall symptom score | 4.4 ± 1.0 | 4.5 ± 1.0 |
Positive symptom score | 3.8 ± 1.4 | 3.9 ± 1.4 |
Negative symptom score | 4.1 ± 1.3 | 4.2 ± 1.3 |
Depressive symptom score | 3.4 ± 1.3 | 3.9 ± 1.4 |
Cognitive symptom score | 3.8 ± 1.3 | 3.9 ± 1.3 |
BMI | 26.2 ± 4.9 | 26.0 ± 4.8 |
Adverse events (% pat) | ||
Extrapyramidal symptoms | 37.4% | 41.7% |
Tardive dyskinesia | 9.1% | 12.4% |
Loss of libido | 46.0% | 50.1% |
Impotence | 34.1% | 40.3% |
Amenorrohea | 10.5% | 17.2% |
Galactorrohea | 1.9% | 5.0% |
Gynecomastia | 2.9% | 5.8% |